Pharmaceutical NEWS - Spring 2008

Drs. Duff, Kauffman publish paper

Lancaster Labs’ director Dr. Jon S. Kauffman and manager Dr. Robert J. Duff as well as Jacek Cieslak, Andrzej Grajkowski and Serge L. Beaucage of the FDA-CDER, Division of Therapeutic Proteins, published “The 4-(N-Dichloroacetyl-N-methylamino) benzyloxymethyl Group for 2’-Hydroxyl Protection of Ribonucleosides in the Solid-Phase Synthesis of Oligoribonucleotides,” in the Journal of Organic Chemistry, 2774-2783, 2008.